Primary |
Product Used For Unknown Indication |
23.7% |
Glaucoma |
21.1% |
Asthma |
10.5% |
Hypertension |
10.5% |
Intraocular Pressure Increased |
5.3% |
Intraocular Pressure Test Abnormal |
5.3% |
Type 2 Diabetes Mellitus |
5.3% |
Anticoagulant Therapy |
2.6% |
Epilepsy |
2.6% |
Fungal Infection |
2.6% |
Headache |
2.6% |
Hypercholesterolaemia |
2.6% |
Hypertensive Cardiomyopathy |
2.6% |
Hyperthyroidism |
2.6% |
|
Cerebral Vasoconstriction |
15.0% |
Atrial Fibrillation |
10.0% |
Somnolence |
10.0% |
Wound |
10.0% |
Adverse Event |
5.0% |
Anosmia |
5.0% |
Blindness Unilateral |
5.0% |
Drug Dose Omission |
5.0% |
Insomnia |
5.0% |
Intraocular Pressure Increased |
5.0% |
Sexual Dysfunction |
5.0% |
Sjogren's Syndrome |
5.0% |
Sternal Fracture |
5.0% |
Therapy Cessation |
5.0% |
Xerosis |
5.0% |
|
Secondary |
Glaucoma |
37.2% |
Drug Use For Unknown Indication |
18.6% |
Cataract |
9.3% |
Intraocular Pressure Increased |
7.0% |
Product Used For Unknown Indication |
7.0% |
Fungal Infection |
4.7% |
Hypertension |
4.7% |
Ocular Hypertension |
4.7% |
Arrhythmia |
2.3% |
Major Depression |
2.3% |
Normal Tension Glaucoma |
2.3% |
|
Off Label Use |
27.8% |
Intraocular Pressure Decreased |
11.1% |
Sjogren's Syndrome |
11.1% |
Vitreous Disorder |
11.1% |
Anosmia |
5.6% |
Atrioventricular Block |
5.6% |
Corneal Oedema |
5.6% |
Malaise |
5.6% |
Ocular Hyperaemia |
5.6% |
Somnolence |
5.6% |
Visual Acuity Reduced |
5.6% |
|
Concomitant |
Glaucoma |
18.0% |
Behcet's Syndrome |
12.7% |
Prophylaxis |
12.1% |
Product Used For Unknown Indication |
8.5% |
Hypertension |
6.1% |
Ocular Hypertension |
4.7% |
Castleman's Disease |
3.8% |
Cataract |
3.4% |
Drug Use For Unknown Indication |
3.2% |
Keratitis |
3.2% |
Sinusitis |
3.2% |
Cancer Pain |
3.0% |
Diabetes Mellitus |
3.0% |
Osteoporosis |
3.0% |
Constipation |
2.5% |
Thrombosis Prophylaxis |
2.3% |
Arthritis |
1.9% |
Depression |
1.9% |
Gastritis |
1.9% |
Insomnia |
1.9% |
|
Intraocular Pressure Increased |
11.1% |
Visual Acuity Reduced |
7.9% |
Asthma |
6.3% |
Cataract |
6.3% |
Drug Ineffective |
6.3% |
Pelvic Mass |
6.3% |
Visual Impairment |
6.3% |
Glaucoma |
4.8% |
Pyrexia |
4.8% |
Urinary Tract Infection |
4.8% |
Vomiting |
4.8% |
White Blood Cell Count Decreased |
4.8% |
Cerebral Haemorrhage |
3.2% |
Convulsion |
3.2% |
Dehydration |
3.2% |
Epilepsy |
3.2% |
Hypotension |
3.2% |
Infusion Related Reaction |
3.2% |
Injury |
3.2% |
Interstitial Lung Disease |
3.2% |
|